This Article Full Text Full Text (PDF) All Versions of this Article: M2602v1 15/4/424    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matheny, M. E. Articles by Gandhi, T. K. Search for Related Content PubMed PubMed Citation Articles by Matheny, M. E. Articles by Gandhi, T. K.

A Randomized Trial of Electronic Clinical Reminders to Improve Medication Laboratory Monitoring

^a Division of General Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
^b Decision Systems Group, Department of Radiology, Brigham & Women's Hospital, Boston, MA
^c Department of Health Care Policy, Harvard Medical School, Boston, MA
^d Massachusetts College of Pharmacy and Health Sciences, Cambridge, MA
^e Partners HealthCare System, Boston, MA.

^_* Correspondence: Tejal K. Gandhi, MD, MPH, BWH Division of General Medicine, 1620 Tremont Street, Boston, MA 02120 (Email: tgandhi{at}partners.org).

Received for publication: 08/22/07; accepted for publication: 03/11/08.

Objective: Recommendations for routine laboratory monitoring to reduce the risk of adverse medication events are not consistently followed. We evaluated the impact of electronic reminders delivered to primary care physicians on rates of appropriate routine medication laboratory monitoring.

Design: We enrolled 303 primary care physicians caring for 1,922 patients across 20 ambulatory clinics that had at least one overdue routine laboratory test for a given medication between January and June 2004. Clinics were randomized so that physicians received either usual care or electronic reminders at the time of office visits focused on potassium, creatinine, liver function, thyroid function, and therapeutic drug levels.

Measurements: Primary outcomes were the receipt of recommended laboratory monitoring within 14 days following an outpatient clinic visit. The effect of the intervention was assessed for each reminder after adjusting for clustering within clinics, as well as patient and provider characteristics.

Results: Medication-laboratory monitoring non-compliance ranged from 1.6% (potassium monitoring with potassium-supplement use) to 6.3% (liver function monitoring with HMG CoA Reductase Inhibitor use). Rates of appropriate laboratory monitoring following an outpatient visit ranged from 14% (therapeutic drug levels) to 64% (potassium monitoring with potassium-sparing diuretic use). Reminders for appropriate laboratory monitoring had no impact on rates of receiving appropriate testing for creatinine, potassium, liver function, renal function, or therapeutic drug level monitoring.

Conclusion: We identified high rates of appropriate laboratory monitoring, and electronic reminders did not significantly improve these monitoring rates. Future studies should focus on settings with lower baseline adherence rates and alternate drug-laboratory combinations.

This article has been cited by other articles:

				H. G. Lo, M. E. Matheny, D. L. Seger, D. W. Bates, and T. K. Gandhi Impact of Non-interruptive Medication Laboratory Monitoring Alerts in Ambulatory Care J. Am. Med. Inform. Assoc., January 1, 2009; 16(1): 66 - 71. [Abstract] [Full Text] [PDF]